Two cases of acute lymphoblastic leukemia with an e1a3 BCR-ABL1 fusion transcript

Ann Lab Med. 2015 Jan;35(1):159-61. doi: 10.3343/alm.2015.35.1.159. Epub 2014 Dec 8.

Authors

Sang-Yong Shin¹, Jin-Hee Cho¹, Hee-Jin Kim¹, Jun-Ho Jang², Seung-Tae Lee¹, Sun-Hee Kim¹

Affiliations

¹ Department of Laboratory Medicine & Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
² Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents / therapeutic use
Base Sequence
DNA / chemistry
DNA / genetics
DNA / metabolism
DNA Mutational Analysis
Fusion Proteins, bcr-abl / genetics*
Genotype
Humans
Imatinib Mesylate / therapeutic use
Karyotyping
Male
Multiplex Polymerase Chain Reaction
Mutation
Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*

Substances

Antineoplastic Agents
BCR-ABL1 fusion protein, human
Imatinib Mesylate
DNA
Fusion Proteins, bcr-abl